Acute effects

January 9, 2026

Sex-specific association between low oral doses of cannabidiol (CBD) and plasma concentration of anandamide (AEA), N-palmitoylethanolamine (PEA) and N-oleoylethanolamine (OEA) in healthy occasional cannabis users

Abstract Background: Cannabidiol (CBD), a phytocannabinoid produced by Cannabis sativa, is widely consumed and interacts with components of the endocannabinoid…

May 7, 2025

Assessment of the associative determinants of tolerance to the effects of cannabis extract on exploratory behavior in rats

Abstract Experimental evaluation of cannabis tolerance has lacked an associative learning approach, focusing primarily on physiological variables. The present study…

April 1, 2024

Perceptions and engagement of patients with chronic conditions on the use of medical cannabis: a scoping review

Abstract Context: Studies generally focus on one type of chronic condition and the effect of medical cannabis (MC) on symptoms;…

August 23, 2018

Feasibility and Effects of Digital Interventions to Support People in Recovery From Substance Use Disorders: Systematic Review

Abstract Background: The development and evaluation of digital interventions aimed at preventing or treating substance use–related problems and disorders is…

January 25, 2012

Pharmacological interventions in the treatment of the acute effects of cannabis: a systematic review of literature

Abstract Background: Cannabis intoxication is related to a number of physical and mental health risks with ensuing social costs. However,…

October 6, 2010

Acute effects of MDMA (3,4-methylenedioxymethamphetamine) on EEG oscillations: alone and in combination with ethanol or THC (delta-9-tetrahydrocannabinol)

Abstract Rationale: Typical users of 3,4-methylenedioxymethamphetamine (MDMA or “ecstasy”) are polydrug users, combining MDMA with alcohol or cannabis [most active…